Skip to content
Home/Companies/MedTech/Cadence Neuroscience
Cadence Neuroscience

Cadence Neuroscience

MedTech·US·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Cadence Neuroscience?

Cadence Neuroscience is currently owned by Angelini Ventures through Angelini Ventures (2022 vintage), since 2023.

Hand-verified · updated 2026-07-26

Angelini Ventures
Investor
Angelini Ventures
Angelini Ventures · 2022 · Life Sciences VC

Key facts

HQUnited States
SectorMedTech
StatusActive
Websitecadenceneuro.com

More from Angelini Ventures

Other portfolio companies in the same fund.

Handspring Health
Active
HealthTechUS· 2026
Hypervision Surgical
Active
MedTechUK· 2026
Adcytherix
Active
BiotechFrance· 2025
Elkedonia
Elkedonia
Active
BiotechFrance· 2025
Laigo Bio
Laigo Bio
Active
BiotechNetherlands· 2025
Nobi
Active
MedTechBelgium· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Cadence Neuroscience

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Cadence Neuroscience?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Cadence Neuroscience.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue